{4-[(tert-Butoxycarbonyl)amino]phenyl}acetic acid, 97.0%, 1g

tert-Butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate, 97%, 100mg

2-phenylacetylenesulfonamide, 98.0%, 10mg

Ammonium hydrogen carbonate, min. 98%, Ph.Eur., BP, 500 g, plastic packaging.

Mono-6-O-mesitylenesulfonyl-gamma-cyclodextrin>90.0%(HPLC)1g

2-Hydroxy-3-(thiophen-2-yl)propanoic acid, 95%, 500mg

N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine, 95.0%, 1kg

3-Anilinoacraldehyde anil hydrochloride salt, 98.0%, 1g

ETHYL 2,5-DIFLUORO-4-NITROBENZOATE, 97%, 10g

2,4,6-Tribromophenyl acrylate, 95.0%, 25g

2-PHENYLCYCLOBUTANAMINE HYDROCHLORIDE, 95.0%, 1g

Z-DL-aspartic acid b-benzyl ester, 99.0%, 5g

ethyl 6-(2-fluorophenyl)-6-oxohexanoate, 97.0%, 1g